NO20090027L - Ny analog av vasoaktivt tarmpeptid - Google Patents

Ny analog av vasoaktivt tarmpeptid

Info

Publication number
NO20090027L
NO20090027L NO20090027A NO20090027A NO20090027L NO 20090027 L NO20090027 L NO 20090027L NO 20090027 A NO20090027 A NO 20090027A NO 20090027 A NO20090027 A NO 20090027A NO 20090027 L NO20090027 L NO 20090027L
Authority
NO
Norway
Prior art keywords
vasoactive intestinal
intestinal peptide
new analog
analog
new
Prior art date
Application number
NO20090027A
Other languages
English (en)
Norwegian (no)
Inventor
David Robert Bolin
Wajiha Khan
Hanspeter Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20090027L publication Critical patent/NO20090027L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20090027A 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid NO20090027L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81880506P 2006-07-06 2006-07-06
PCT/EP2007/056351 WO2008003612A2 (en) 2006-07-06 2007-06-26 Analogs of vasoactive intestinal peptide

Publications (1)

Publication Number Publication Date
NO20090027L true NO20090027L (no) 2009-01-15

Family

ID=38786842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090027A NO20090027L (no) 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid

Country Status (20)

Country Link
US (1) US20080096807A1 (es)
EP (1) EP2041168A2 (es)
JP (1) JP2009542593A (es)
KR (1) KR20090027239A (es)
CN (1) CN101484468A (es)
AR (1) AR061825A1 (es)
AU (1) AU2007271274A1 (es)
BR (1) BRPI0714306A2 (es)
CA (1) CA2656757A1 (es)
CL (1) CL2007001956A1 (es)
CR (1) CR10518A (es)
EC (1) ECSP099029A (es)
IL (1) IL196122A0 (es)
MA (1) MA30590B1 (es)
MX (1) MX2009000013A (es)
NO (1) NO20090027L (es)
PE (1) PE20081000A1 (es)
RU (1) RU2009103811A (es)
TW (1) TW200819139A (es)
WO (1) WO2008003612A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130123460A1 (en) 2010-04-30 2013-05-16 Sanwa Kagaku Kenkyusho Co., Ltd. Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability
CN102827268B (zh) * 2011-06-13 2016-08-24 中肽生化有限公司 新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en) 2011-06-21 2014-10-21 Mitel Networks Corporation Conferencing and collaboration system and methods thereof
EP2968469A4 (en) 2013-03-15 2016-08-31 Longevity Biotech Inc PEPTIDES COMPRISING NON-ENDOGENIC AMINO ACIDS AND METHODS OF MAKING AND USING SAME
CA2947982C (en) * 2014-05-08 2022-11-29 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
ITUB20159175A1 (it) * 2015-12-23 2017-06-23 Materie Plastiche Pisane S R L Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879371A (en) * 1971-09-17 1975-04-22 Sami I Said Isolation of vasoactive intestinal peptide
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
WO1997029126A1 (en) * 1996-02-09 1997-08-14 F. Hoffmann-La Roche Ag Synthesis of vip analog
US20050203009A1 (en) * 2004-03-12 2005-09-15 Bayer Pharmaceuticals Corporation VPAC1 selective antagonists and their pharmacological methods of use
US20080146500A1 (en) * 2004-08-18 2008-06-19 Bengt Krister Bokvist Selective Vpac2 Receptor Peptide Agonists
EP1804820A4 (en) * 2004-10-08 2009-12-02 Transition Therapeutics Inc PHARMACEUTICAL PRODUCTS BASED ON VASOACTIVE INTESTINAL POLYPEPTIDES

Also Published As

Publication number Publication date
WO2008003612A2 (en) 2008-01-10
RU2009103811A (ru) 2010-08-20
KR20090027239A (ko) 2009-03-16
AR061825A1 (es) 2008-09-24
WO2008003612A3 (en) 2008-02-28
ECSP099029A (es) 2009-02-27
CR10518A (es) 2009-01-27
MX2009000013A (es) 2009-01-23
CA2656757A1 (en) 2008-01-10
PE20081000A1 (es) 2008-08-06
BRPI0714306A2 (pt) 2014-05-20
CL2007001956A1 (es) 2008-04-18
US20080096807A1 (en) 2008-04-24
IL196122A0 (en) 2011-08-01
EP2041168A2 (en) 2009-04-01
AU2007271274A1 (en) 2008-01-10
MA30590B1 (fr) 2009-07-01
TW200819139A (en) 2008-05-01
JP2009542593A (ja) 2009-12-03
CN101484468A (zh) 2009-07-15

Similar Documents

Publication Publication Date Title
NO20090027L (no) Ny analog av vasoaktivt tarmpeptid
WO2008149150A3 (en) Polypeptides, antibody variable domains and antagonists
TW200708513A (en) Novel crystalline forms of tiotropium bromide
WO2008149144A3 (en) Polypeptides, antibody variable domains and antagonists
WO2006117300A3 (en) Crystalline forms of tiotropium bromide
WO2008082613A3 (en) Factor ix moiety-polymer conjugates having a releasable linkage
TW200738632A (en) Cannabinoid receptor modulators
WO2007076260A3 (en) Farnesoid x receptor agonists
TW200724541A (en) Imidazoquinolines as lipid kinase inhibitors
HK1131790A1 (en) High affinity human antibodies to human il-4 receptor
WO2008070111A3 (en) Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
EA201100133A1 (ru) Антагонисты рецепторов простагландина d
MX2011008799A (es) Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
EP3087988A3 (en) Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
MX2009001534A (es) Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
WO2010048477A3 (en) Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates
WO2007079163A3 (en) Prokineticin 1 receptor antagonists
TW200716566A (en) Prokineticin 2 receptor antagonists
NO20091741L (no) Pyrazolinforbindelser som mineralkortikoidreceptorantagonister
CY1114636T1 (el) Αγωγη συμπτωματων της νοσου του parkinson με αλκυλαμινες χωρις ιμιδαζολιο ως προσδετες η3-υποδοχεα ισταμινης
GT200900075A (es) Antagonistas de ccr2 para el tratamineto de fibrosis
MXPA04010625A (es) Antagonista de receptor de taquicinina.
MX2009008527A (es) Compuestos de amonio cuaternario y difenilmetilo utiles como antagonistas del receptor muscarinico.
SG154441A1 (en) Treatment of demyelinating disorders
MX2011008336A (es) Derivados de dihidroquinolinona.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application